Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-23-018062

Chief Financial Officer sold 7,661 shares at an average $20.54 ($157,367)

  • Chief Financial Officer acquired 7,567 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Graham Juan Chief Financial Officer 2023-03-08 Sale −2,749 $21.16 $58,158 70,213 D: show line 1 in the form
Graham Juan Chief Financial Officer 2023-03-08 Grant or award +2,899 73,112 D: show line 2 in the form
Graham Juan Chief Financial Officer 2023-03-08 Grant or award +4,668 77,780 D: show line 3 in the form
Graham Juan Chief Financial Officer 2023-03-10 Sale −1,112 $20.20 $22,459 76,668 D: show line 4 in the form
Graham Juan Chief Financial Officer 2023-03-10 Sale −1,456 $20.20 $29,407 75,212 D: show line 5 in the form
Graham Juan Chief Financial Officer 2023-03-10 Sale −2,344 $20.20 $47,342 72,868 D: show line 6 in the form
Open-market sales · 7,661 sh · avg $20.54 · $157,367
Loading xslF345X03/doc4.xml…